- Home
- INBS vs MEGL Comparison
INBS vs MEGL Comparison
Compare INBS & MEGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INBS
- MEGL
- Stock Information
- Founded
- INBS 2016
- MEGL 2016
- Country
- INBS United States
- MEGL Hong Kong
- Employees
- INBS N/A
- MEGL N/A
- Industry
- INBS Medical Specialities
- MEGL Finance: Consumer Services
- Sector
- INBS Health Care
- MEGL Finance
- Exchange
- INBS Nasdaq
- MEGL Nasdaq
- Market Cap
- INBS 6.4M
- MEGL 6.8M
- IPO Year
- INBS N/A
- MEGL 2022
- Fundamental
- Price
- INBS $0.69
- MEGL $1.19
- Analyst Decision
- INBS
- MEGL
- Analyst Count
- INBS 0
- MEGL 0
- Target Price
- INBS N/A
- MEGL N/A
- AVG Volume (30 Days)
- INBS 265.2K
- MEGL 42.5K
- Earning Date
- INBS 11-12-2025
- MEGL 12-11-2025
- Dividend Yield
- INBS N/A
- MEGL N/A
- EPS Growth
- INBS N/A
- MEGL N/A
- EPS
- INBS N/A
- MEGL N/A
- Revenue
- INBS $3,292,042.00
- MEGL $1,296,394.00
- Revenue This Year
- INBS $778.48
- MEGL N/A
- Revenue Next Year
- INBS N/A
- MEGL N/A
- P/E Ratio
- INBS N/A
- MEGL N/A
- Revenue Growth
- INBS 3.26
- MEGL N/A
- 52 Week Low
- INBS $0.64
- MEGL $1.02
- 52 Week High
- INBS $2.75
- MEGL $5.52
- Technical
- Relative Strength Index (RSI)
- INBS 30.21
- MEGL 37.78
- Support Level
- INBS $0.64
- MEGL $1.18
- Resistance Level
- INBS $0.69
- MEGL $1.38
- Average True Range (ATR)
- INBS 0.05
- MEGL 0.07
- MACD
- INBS 0.00
- MEGL -0.01
- Stochastic Oscillator
- INBS 17.04
- MEGL 18.18
About INBS Intelligent Bio Solutions Inc.
Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company operates through new reportable segments: United Kingdom; Asia Pacific (APAC); Americas; and Rest of World, of which United Kingdom derives maximum revenue.
About MEGL Magic Empire Global Limited
Magic Empire Global Ltd is a financial services provider in Hong Kong which principally engage in the provision of corporate finance advisory services and underwriting services. The companys offerings mainly comprise of IPO sponsorship services, Financial advisory and independent financial advisory services, Compliance advisory services, Underwriting services, Corporate service.